Pliant Therapeutics, Inc.
PLRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001746473
No open-market purchases or sales by Pliant Therapeutics, Inc. insiders were filed in the last 90 days; 86 institutions reported holding it in 13F filings for Q2 2026, worth $54.8M in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in Pliant Therapeutics, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 98
- +1 vs. Q3 2025
- Shares held
- 46.7M
- −3.59M (−7.1%) vs. Q3 2025
- Total value
- $57.0M
- −$17.6M (−23.6%) vs. Q3 2025
- New holders
- 15
- 30 more added
- Sold out
- 14
- 34 more reduced
3 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PLRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 86 | $54.8M |
| Q1 2026 | 91 | $62.5M |
| Q4 2025 | 98 | $57.0M |
| Q3 2025 | 100 | $74.7M |
| Q2 2025 | 114 | $59.7M |
| Q1 2025 | 141 | $78.5M |
| Q4 2024 | 161 | $852.6M |
| Q3 2024 | 151 | $710.6M |
| Q2 2024 | 144 | $687.2M |
| Q1 2024 | 135 | $971.3M |
| Q4 2023 | 134 | $1.14B |
| Q3 2023 | 136 | $1.04B |
| Q2 2023 | 144 | $1.05B |
| Q1 2023 | 143 | $1.50B |
| Q4 2022 | 125 | $864.1M |
| Q3 2022 | 110 | $948.1M |
| Q2 2022 | 88 | $241.5M |
| Q1 2022 | 92 | $222.1M |
| Q4 2021 | 88 | $416.5M |
| Q3 2021 | 77 | $512.8M |
| Q2 2021 | 81 | $893.6M |
| Q1 2021 | 76 | $1.21B |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Pliant Therapeutics, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Catalyst Funds Management Pty Ltd | 0 | $0 | 0.00% | −59,539−100.0% | Sold out |
| Bluefin Capital Management, LLC | 0 | $0 | 0.00% | – | Sold out |
| Jain Global LLC | 0 | $0 | 0.00% | −25,037−100.0% | Sold out |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −25,400−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −20,749−100.0% | Sold out |
| China Universal Asset Management Co., Ltd. | 0 | $0 | 0.00% | −10,760−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −4,319−100.0% | Sold out |
| Mirae Asset Global Investments Co., Ltd. | 0 | $0 | 0.00% | −2,373−100.0% | Sold out |
| GF Fund Management Co. Ltd. | 0 | $0 | 0.00% | −1,264−100.0% | Sold out |
| Rise Advisors, LLC | 0 | $0 | 0.00% | −740−100.0% | Sold out |
| Bell Investment Advisors, Inc | 0 | $0 | 0.00% | −307−100.0% | Sold out |
| Daiwa Securities Group Inc. | 0 | $0 | 0.00% | −196−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | – | – | – | – | Not filed |
| Point72 Asia (Singapore) Pte. Ltd. | – | – | – | – | Not filed |
| Point72 (DIFC) Ltd | – | – | – | – | Not filed |